This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Garber, K. Industry makes strides in melanoma. Nat Biotechnol 28, 763–764 (2010). https://doi.org/10.1038/nbt0810-763
Issue Date:
DOI: https://doi.org/10.1038/nbt0810-763
This article is cited by
-
Gene expression profiling of anti-CTLA4-treated metastatic melanoma in patients with treatment-induced autoimmunity
Laboratory Investigation (2017)
-
Metastasiertes malignes Melanom
Der Hautarzt (2013)
-
Melanoma antibody approved
Nature Biotechnology (2011)
-
Oncology's energetic pipeline
Nature Biotechnology (2010)